N Verses Capital, LLC Dynavax Technologies Corp Transaction History
N Verses Capital, LLC
- $219 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
260Shares Held
132MCall Options Held
371KPut Options Held
99.2K-
Black Rock Inc. New York, NY21.9MShares$263 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT10.9MShares$131 Million4.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.37MShares$113 Million0.0% of portfolio
-
State Street Corp Boston, MA7.96MShares$95.7 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA7.15MShares$85.9 Million0.19% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.52B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...